Neurocutaneous Disorders: Cerebrotendinous xanthomatosis

[1]  A. Honda,et al.  Side Chain Hydroxylations in Bile Acid Biosynthesis Catalyzed by CYP3A Are Markedly Up-regulated in Cyp27−/− Mice but Not in Cerebrotendinous Xanthomatosis* , 2001, The Journal of Biological Chemistry.

[2]  Y. Eto,et al.  Frontal lobe dementia with abnormal cholesterol metabolism and heterozygous mutation in sterol 27-hydroxylase gene (CYP27) , 2001, Journal of Inherited Metabolic Disease.

[3]  D. Russell,et al.  Disruption of the Sterol 27-Hydroxylase Gene in Mice Results in Hepatomegaly and Hypertriglyceridemia , 2000, The Journal of Biological Chemistry.

[4]  F. Gabreëls,et al.  Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings. , 2000, Radiology.

[5]  F. Gabreëls,et al.  Cerebrotendinous xanthomatosis Controversies about nerve and muscle: observations in ten patients , 2000, Neuromuscular Disorders.

[6]  F. Gabreëls,et al.  Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. , 2000, Brain : a journal of neurology.

[7]  F. Gabreëls,et al.  Presence of diarrhea and absence of tendon xanthomas in patients with cerebrotendinous xanthomatosis. , 2000, Archives of neurology.

[8]  F. Gabreëls,et al.  Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis. , 1999, Brain : a journal of neurology.

[9]  F. Gabreëls,et al.  Effect of simvastatin in addition to chenodeoxycholic acid in patients with cerebrotendinous xanthomatosis. , 1999, Metabolism: clinical and experimental.

[10]  M. Osame,et al.  Pulmonary manifestations in cerebrotendinous xanthomatosis. , 1998, Internal medicine.

[11]  N. Maeda,et al.  Markedly Reduced Bile Acid Synthesis but Maintained Levels of Cholesterol and Vitamin D Metabolites in Mice with Disrupted Sterol 27-Hydroxylase Gene* , 1998, The Journal of Biological Chemistry.

[12]  J. Cruysberg,et al.  Treatment and follow-up of children with cerebrotendinous xanthomatosis , 1998, European Journal of Pediatrics.

[13]  J. Cruysberg,et al.  Ocular and systemic manifestations of cerebrotendinous xanthomatosis. , 1995, American journal of ophthalmology.

[14]  N. Javitt.  Bile acid synthesis from cholesterol: regulatory and auxiliary pathways , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  Y. Tokimura,et al.  Treatment of cerebrotendinous xanthomatosis: effects of chenodeoxycholic acid, pravastatin, and combined use , 1994, Journal of the Neurological Sciences.

[16]  G. Tint,et al.  Comparative effects of lovastatin and chenodeoxycholic acid on plasma cholestanol levels and abnormal bile acid metabolism in cerebrotendinous xanthomatosis. , 1994, Metabolism: clinical and experimental.

[17]  A. Korczyn,et al.  Magnetic resonance imaging in cerebrotendinous xanthomatosis: A prospective clinical and neuroradiological study , 1994, Journal of the Neurological Sciences.

[18]  V. Meiner,et al.  Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews or Moroccan origin. , 1993, The Journal of clinical investigation.

[19]  J. Cruysberg,et al.  Juvenile cataract associated with chronic diarrhea in pediatric cerebrotendinous xanthomatosis. , 1991, American journal of ophthalmology.

[20]  M. Osame,et al.  Atherogenic risk factors in cerebrotendinous xanthomatosis. , 1991, Clinica chimica acta; international journal of clinical chemistry.

[21]  Y. Seyama,et al.  Cerebrotendinous xanthomatosis: Clinical and biochemical evaluation of eight patients and review of the literature , 1991, Journal of the Neurological Sciences.

[22]  L. Prockop,et al.  Magnetic resonance imaging of the brain and spinal cord in cerebrotendinous xanthomatosis. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[23]  J. C. van der Molen,et al.  Bile acid therapies applied to patients suffering from cerebrotendinous xanthomatosis. , 1985, Clinica chimica acta; international journal of clinical chemistry.

[24]  S. Shefer,et al.  Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. , 1984, The New England journal of medicine.

[25]  C. Gips,et al.  Capillary gas chromatographic determination of cholestanol/cholesterol ratio in biological fluids. Its potential usefulness for the follow-up of some liver diseases and its lack of specificity in diagnosing CTX (cerebrotendinous xanthomatosis). , 1984, Clinica chimica acta; international journal of clinical chemistry.

[26]  J. C. van der Molen,et al.  Diagnosis of cerebrotendinous xanthomatosis (CTX) and effect of chenodeoxycholic acid therapy by analysis of urine using capillary gas chromatography. , 1983, Clinica chimica acta; international journal of clinical chemistry.

[27]  I. Björkhem,et al.  Cerebrotendinous xanthomatosis: a defect in mitochondrial 26-hydroxylation required for normal biosynthesis of cholic acid. , 1980, The Journal of clinical investigation.

[28]  G. Salen,et al.  Chenodeoxycholic acid inhibits increased cholesterol and cholestanol synthesis in patients with cerebrotendinous xanthomatosis. , 1975, Biochemical medicine.

[29]  G. Tint,et al.  A biochemical abnormality in cerebrotendinous xanthomatosis. Impairment of bile acid biosynthesis associated with incomplete degradation of the cholesterol side chain. , 1974, The Journal of clinical investigation.

[30]  G. Salen.  Cholestanol deposition in cerebrotendinous xanthomatosis. A possible mechanism. , 1971, Annals of internal medicine.

[31]  P. Swanson,et al.  Cerebrotendinous Xanthomatosis: The Storage of Cholestanol Within the Nervous System , 1968 .

[32]  M. Nakagawa,et al.  Cerebrotendinous xanthomatosis: cranial CT and MRI studies in eight patients , 2004, Neuroradiology.

[33]  D. Benharroch,et al.  The neuropathology of cerebrotendinous xanthomatosis revisited: a case report and review of the literature , 2004, Acta Neuropathologica.

[34]  A. Federico,et al.  Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis. , 2001, Brain : a journal of neurology.

[35]  D. Gazit,et al.  Osteoporosis and increased bone fractures in cerebrotendinous xanthomatosis. , 1993, Metabolism: clinical and experimental.